CITF COVID-19 Immunity Task Force Databank

CanPath and its regional cohorts, including Atlantic PATH, are proud to be part of the COVID-19 Immunity Task Force (CITF) Databank with our COVID-19 serology study that includes participants across the country. The CITF Databank data holdings include data from 21 studies, including six multi-province studies “representing a wide range of population and community data from Read more about CITF COVID-19 Immunity Task Force Databank[…]

Ontario Institute for Cancer Research: Ask a Researcher

The Ontario Institute for Cancer Research (OICR) has interviewed our colleague, Dr. Kimberly Skead as part of Science Literacy Week. Dr. Skead answers a question about how blood changes as we age and implications for the prediction, detection and diagnosis of cancer. Credit: Ontario Institute for Cancer Research: https://www.youtube.com/watch?v=CMB79lFBSqs) You can find the Ask a Cancer Read more about Ontario Institute for Cancer Research: Ask a Researcher[…]

Upcoming Webinar: Empowering Breast Health: Personalized Approaches to Canadian Breast Cancer Screening

Join CanPath for an upcoming webinar from CanPath’s incoming Executive Director, Dr. Jennifer Brooks entitled, “Empowering Breast Health: Personalized Approaches to Canadian Breast Cancer Screening” on  Thursday, October 19th from 12-1pmEST/1-2pmAST. Details and registration info: https://canpath.ca/2023/09/webinar-breast-cancer-screening-brooks/

Celebrating Dr. John McLaughlin and Welcoming Dr. Jennifer Brooks

Dr. John McLaughlin is retiring as CanPath Executive Director and has been awarded Professor Emeritus status at the University of Toronto, while Dr. Jennifer Brooks will assume the role starting October 2, 2023. It has been a true pleasure for our Atlantic PATH team members to work with Dr. McLaughlin. He will be missed and Read more about Celebrating Dr. John McLaughlin and Welcoming Dr. Jennifer Brooks[…]

CanPath is Hiring: Research Operations Manager

Join the CanPath team as the new Research Operations Manager at the University of Toronto. Deadline: September 22, 2023. “CanPath is Canada’s largest population health cohort and a national platform for population-level health research. CanPath is studying the biology, behaviours and environments of Canadians to learn more about the causes of chronic disease and cancer Read more about CanPath is Hiring: Research Operations Manager[…]

CanPath Scientific Director presents at AGBT Meeting

Advances in Genome Biology and Technology (AGBT) is “considered the preeminent genome science and technology conference where top global researchers, leaders and innovators meet to announce new discoveries, cutting edge breakthroughs and to collaborate.” CanPath Scientific Director, Dr. Philip Awadalla attended the AGBT Precision Health meeting in San Diego, California from September 7-9, 2023. Dr. Read more about CanPath Scientific Director presents at AGBT Meeting[…]

CH&E Seminar Series – Dr. Kelvin Fong (Sept 2023)

We are looking forward to attend our colleague, Dr. Kelvin Fong’s presentation in the Dalhousie University Department of Community Health and Epidemiology‘s Seminar Series on September 13th at 12pm AST (11am EST). Dr. Fong’s presentation is entitled, “How does the Environment Contribute to Health in Atlantic Canada?”  Dr. Fong is an assistant professor at Dalhousie University Read more about CH&E Seminar Series – Dr. Kelvin Fong (Sept 2023)[…]

Melanoma Risk in Atlantic Canada

New work from Dr. Ivan Litvinov and Dr. François Lagacé  at McGill University includes Atlantic PATH participants and highlights why Atlantic Canadians are at higher risk for developing melanoma (skin cancer). The SunFit project conducted focus groups in 22 communities across Atlantic Canada.  Nova Scotia and Prince Edward Island have the highest rates of melanoma in the Read more about Melanoma Risk in Atlantic Canada[…]

Depression, Anxiety, and the Risk of Cancer: An Individual Participant Data Meta-Analysis

Authors: LonnekeA. van Tuijl, Maartje Basten, Kuan‐Yu Pan, Roel Vermeulen, Lützen Portengen, Alexander de Graeff, Joost Dekker, Mirjam I. Geerlings, Adriaan Hoogendoorn, Femke Lamers, Adri C. Voogd, Jessica Abell, Philip Awadalla, Aartjan T.F. Beekman, Ottar Bjerkeset, Andy Boyd, |Yunsong Cui, Philipp Frank, Henrike Galenkamp, Bert Garssen, Sean Hellingman, Martijn Huisman, Anke Huss, Trynke R. de Jong, Read more about Depression, Anxiety, and the Risk of Cancer: An Individual Participant Data Meta-Analysis[…]

New Publication – Depression, Anxiety and Risk of Cancer

We are pleased to share that the first results from the Psychosocial Factors and Cancer Incidence (PSY-CA) consortium have been published in Cancer. Led from the Netherlands by Dr. Lonneke van Tuijl and Dr. Joost Dekker, this study includes 18 cohorts with more than 300,000 participants including Atlantic PATH, the Ontario Health Study and CARTaGENE Read more about New Publication – Depression, Anxiety and Risk of Cancer[…]